March 15 (Reuters) - Biovica International AB BIOVICb.ST :
* SAID ON MONDAY BIOVICA ESTABLISHES US CLIA LAB TO FURTHER
STRENGTHEN DIVITUM®TKA LAUNCH ON US MARKET
* AIMS TO HAVE ITS LAB OPERATIONAL AND CLIA CERTIFIED DURING
THIRD
QUARTER 2022
* DECIDED TO ESTABLISH A CLIA LAB IN SAN DIEGO, CALIFORNIA
* LOCATION HAS BEEN IDENTIFIED AND A LEASE FOR THE PREMISES
HAS
BEEN SIGNED
* LAB WILL, AFTER THE 510(K) CLEARANCE, OFFER
DIVITUM®TKA-ANALYSIS
TO BIOVICA’S CUSTOMERS IN THE US
Source text for Eikon: urn:newsml:reuters.com:*:nMFN4FX2gz
Further company coverage: [ BIOVICb.ST ]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))